Esophageal cancer linked to osteoporosis drugs
Friday, January 2, 2009 - 03:07
in Health & Medicine
BOSTON (Reuters) - Merck's popular osteoporosis drug Fosamax and other similar drugs may carry a risk for esophageal cancer, a Food and Drug Administration official said on Wednesday.